The heterogeneity of serologic findings and predisposing host factors in drug-induced lupus erythematosus.
D000107:Acetylation; D000974:Antibodies, Antinuclear; D000961:Antilymphocyte Serum; D001172:Arthritis, Rheumatoid / Q000276:immunology; D003168:Complement Fixation Tests; D005260:Female; D000949:Histocompatibility Antigens Class II; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007637:Keratoconjunctivitis / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000276:immunology*; D008297:Male; D010396:Penicillamine / Q000009:adverse effects; D013997:Time Factors
D000974:Antibodies, Antinuclear; D000961:Antilymphocyte Serum; D000949:Histocompatibility Antigens Class II; D006830:Hydralazine; D010396:Penicillamine